Wei Tang Selected Research

atofluding

11/2006

Inhibition of human gastric carcinoma cell growth by atofluding derivative N3-o-toluyl-fluorouracil.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wei Tang Research Topics

Disease

287	Neoplasms (Cancer) 05/2024 - 05/2003
71	Inflammation (Inflammations) 04/2024 - 05/2004
59	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 02/2003
50	Schizophrenia (Dementia Praecox) 10/2023 - 09/2005
46	Breast Neoplasms (Breast Cancer) 02/2024 - 10/2006
45	Infections 04/2024 - 09/2005
45	Neoplasm Metastasis (Metastasis) 02/2024 - 05/2003
26	Asthma (Bronchial Asthma) 01/2024 - 05/2004
25	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 05/2010
23	Carcinoma (Carcinomatosis) 05/2023 - 01/2004
17	Autoimmune Diseases (Autoimmune Disease) 04/2024 - 08/2011
17	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 12/2009
16	Type 2 Diabetes Mellitus (MODY) 01/2024 - 01/2014
16	Carcinogenesis 05/2023 - 09/2003
14	Cognitive Dysfunction 11/2023 - 08/2012
14	Alzheimer Disease (Alzheimer's Disease) 11/2023 - 04/2013
14	Hypoxia (Hypoxemia) 10/2022 - 01/2013
13	Stomach Neoplasms (Stomach Cancer) 05/2024 - 08/2008
13	Fibrosis (Cirrhosis) 12/2023 - 04/2007
13	Lung Neoplasms (Lung Cancer) 11/2023 - 09/2015
12	Pneumonia (Pneumonitis) 04/2024 - 11/2015
12	Insulin Resistance 01/2024 - 04/2012
12	COVID-19 12/2023 - 01/2020
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 01/2015
12	Leukemia 08/2023 - 04/2004
12	Hypersensitivity (Allergy) 01/2022 - 05/2005
12	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2006
11	Colitis 04/2024 - 11/2014
11	Pancreatic Neoplasms (Pancreatic Cancer) 04/2024 - 12/2009
11	Diabetic Nephropathies (Diabetic Nephropathy) 01/2024 - 01/2013
11	Arthritis (Polyarthritis) 10/2022 - 07/2006
10	Respiratory Syncytial Virus Infections 05/2024 - 11/2015
10	Glioma (Gliomas) 01/2024 - 03/2005
10	Pain (Aches) 02/2023 - 12/2010
10	Liver Neoplasms (Liver Cancer) 10/2021 - 05/2003
9	Necrosis 05/2024 - 07/2004
9	Ulcerative Colitis 01/2024 - 10/2018
9	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 01/2018
9	Body Weight (Weight, Body) 01/2022 - 04/2007
9	Lymphatic Metastasis 04/2016 - 01/2005
8	Disease Progression 04/2024 - 01/2017
8	Obesity 01/2024 - 11/2009
8	Diabetes Mellitus 12/2023 - 01/2011
8	Wounds and Injuries (Trauma) 04/2023 - 10/2006
8	Adenocarcinoma 11/2022 - 01/2006
8	Hyperglycemia 08/2022 - 08/2013

Drug/Important Bio-Agent (IBA)

82	Proteins (Proteins, Gene)FDA Link 04/2024 - 05/2003
45	Biomarkers (Surrogate Marker)IBA 12/2023 - 06/2005
34	EnzymesIBA 08/2023 - 09/2007
33	CytokinesIBA 05/2024 - 05/2006
30	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 11/2009
30	Messenger RNA (mRNA)IBA 01/2024 - 01/2004
26	Therapeutic UsesIBA 08/2023 - 09/2006
18	AntigensIBA 12/2023 - 05/2004
16	Antiviral Agents (Antivirals)IBA 01/2022 - 04/2010
14	Long Noncoding RNAIBA 01/2023 - 01/2016
14	Interleukin-17 (Interleukin 17)IBA 08/2022 - 08/2009
13	RNA (Ribonucleic Acid)IBA 04/2024 - 09/2012
13	MicroRNAs (MicroRNA)IBA 01/2024 - 11/2011
13	Interleukin-6 (Interleukin 6)IBA 01/2024 - 12/2008
13	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 08/2011
13	Oxygen (Dioxygen)IBA 03/2022 - 04/2008
13	ProgranulinsIBA 12/2018 - 04/2011
12	Antipsychotic Agents (Antipsychotics)IBA 01/2023 - 04/2009
11	LipidsIBA 05/2024 - 03/2008
11	beta-aminoarteether maleateIBA 01/2022 - 12/2009
11	huachansuIBA 07/2018 - 01/2010
11	MucinsIBA 08/2014 - 09/2005
10	CholesterolIBA 05/2024 - 01/2015
10	ErbB Receptors (EGF Receptor)IBA 11/2023 - 05/2019
10	Small Interfering RNA (siRNA)IBA 01/2023 - 09/2007
10	Olanzapine (Zyprexa)FDA Link 01/2023 - 07/2017
10	NitrogenIBA 01/2022 - 08/2011
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2023 - 12/2008
9	AcidsIBA 10/2023 - 07/2005
9	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 01/2015
9	Phosphotransferases (Kinase)IBA 12/2022 - 01/2011
9	artemisinin (artemisinine)IBA 01/2022 - 01/2012
9	acarboxyprothrombin (PIVKA)IBA 12/2011 - 05/2003
8	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2020
8	InterleukinsIBA 01/2024 - 09/2006
8	HomocysteineIBA 10/2023 - 11/2006
8	InterferonsIBA 08/2023 - 09/2008
8	Indicators and Reagents (Reagents)IBA 05/2023 - 01/2006
8	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2022 - 03/2005
8	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 02/2022 - 08/2009
8	Glutathione (Reduced Glutathione)IBA 01/2022 - 08/2006
8	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 06/2011
8	Monoclonal AntibodiesIBA 01/2021 - 02/2003
8	Interleukin-10 (Interleukin 10)IBA 01/2021 - 05/2007

Therapy/Procedure

113	Therapeutics 05/2024 - 03/2005
34	Drug Therapy (Chemotherapy) 05/2024 - 01/2008
17	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2024 - 04/2010
15	Radiotherapy 02/2024 - 09/2013
11	Immunotherapy 04/2024 - 01/2013
11	Photochemotherapy (Photodynamic Therapy) 11/2022 - 03/2005
11	Precision Medicine 01/2020 - 09/2015
10	Hematopoietic Stem Cell Transplantation 12/2022 - 05/2011
8	Aftercare (After-Treatment) 01/2023 - 04/2008
8	Length of Stay 07/2022 - 10/2013